0000000000593094

AUTHOR

A. Escudero

showing 9 related works from this author

Mitochondrial oxidative stress and CD95 ligand: A dual mechanism for hepatocyte apoptosis in chronic alcoholism

2002

Apoptosis plays an important role in the progression of alcohol-induced liver disease to cirrhosis. Oxidative stress is an early event in the development of apoptosis. The major aim of this study was to study the conditions in which oxidative stress occurs in chronic alcoholism and its relationship with apoptosis of hepatocytes. We have found that oxidative stress is associated with chronic ethanol consumption in humans and in rats, in the former independently of the existence of alcohol-induced liver disease. Ethanol or acetaldehyde induces apoptosis in hepatocytes isolated from alcoholic rats, but not in those from control rats. Inhibition of aldehyde dehydrogenase, but not of cytochrome …

chemistry.chemical_classificationReactive oxygen speciesProgrammed cell deathHepatologyAcetaldehydeMitochondrionCYP2E1Biologymedicine.disease_causeCell biologychemistry.chemical_compoundMitochondrial permeability transition poreBiochemistrychemistryApoptosismedicineOxidative stressHepatology
researchProduct

Effect of micro-oxygenation on the evolution of aromatic compounds in wines: Malolactic fermentation and ageing in wood

2009

Abstract The effect of micro-oxygenation on the aromas of two varietal wines (Tempranillo and Cabernet Sauvignon) when alcoholic fermentation is complete was examined. Several factors, such as whether malolactic fermentation (MLF) took place in barrels or stainless steel vats and ageing time in oak barrels, were taken into account. Major aroma components were studied using GC-FID and minor compounds were studied by GC–MS analysis before and after MLF and after 4 and 8 months of maturation in oak barrels. Sensorial analysis was performed to describe and quantify the different wine notes. Micro-oxygenation affects different compounds but the effect depends to a great extent on the grape varie…

WinebiologyChemistrybusiness.industrydigestive oral and skin physiologytechnology industry and agriculturefood and beveragesFood technologyEthanol fermentationbiology.organism_classificationSensory analysisMalolactic fermentationFermentationFood sciencebusinessAromaFood ScienceWinemakingLWT - Food Science and Technology
researchProduct

Clinical evaluation of drug-induced hepatitis

2005

Objective: to ascertain the epidemiological characteristics, clinical symptoms, and evolution of drug-induced hepatitis over the last 22 years. Experimental design and subjects: an observational, retrospective study between 1982 and 1993, and prospective study between 1994 and 2003. All patients in our department diagnosed with having drug-induced hepatitis were studied analyzing epidemiological (age, sex, cases per year, hospitalization) and clinical features (previous liver disease, hepatic symptoms, laboratory results), and follow-up (complete recovery or chronicity). Results: a total of 61 patients were diagnosed as having drug-induced hepatitis, 26 men and 35 women (57%), mean age 52.4…

AdultMaleDrugmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsEpidemiologyEvolutionmedia_common.quotation_subjectLiver diseaseSex FactorsInternal medicineEpidemiologyHumansMedicineAcute hepatitisProspective cohort studyAgedRetrospective Studiesmedia_commonHepatitisClinical characteristicsbusiness.industryIncidence (epidemiology)Age FactorsGastroenterologyDrugsRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryHospitalizationSpainFemaleObservational studyChemical and Drug Induced Liver InjurybusinessRevista Española de Enfermedades Digestivas
researchProduct

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.

2008

We tested the hypothesis that the presence of bacterial DNA (bactDNA) in ascitic fluid and serum is associated with decreased survival in patients with cirrhosis. In a prospective, multicenter study, we analyzed the clinical evolution of 156 patients with cirrhosis and ascites (first or recurrence) with lower than 250 polymorphonuclear cells (PMN)/L, negative ascites bacteriological culture, and absence of other bacterial infections being admitted for evaluation of largevolume paracentesis, according to the presence of bactDNA at admission. Survival, causes of death, and successive hospital admissions were determined during a 12-month follow-up period. BactDNA was detected in 48 patients. T…

AdultDNA BacterialLiver CirrhosisMalemedicine.medical_specialtyCirrhosisNeutrophilsKaplan-Meier EstimatePeritonitisGastroenterologyLiver diseaseSpontaneous bacterial peritonitisRisk FactorsInternal medicineAscitesParacentesisEscherichia coliMedicineAscitic FluidHumansProspective StudiesProspective cohort studyCause of deathAgedAged 80 and overHepatologymedicine.diagnostic_testbusiness.industryIncidenceAscitesHepatologyMiddle Agedmedicine.diseasePrognosisSurgeryMultivariate AnalysisFemalemedicine.symptombusinessLiver FailureFollow-Up StudiesHepatology (Baltimore, Md.)
researchProduct

Clinical significance of abdominal lymphadenopathy in chronic liver disease

2002

Abstract The possibility of assessing the relationship of ultrasound (US)-detected abdominal lymphadenopathy with etiology, biochemical findings, and histologic data in patients with chronic liver disease was evaluated. US examination of the upper abdomen was performed in 321 consecutive patients with various chronic liver disorders and 56 control patients. The prevalence of lymphadenopathy in chronic liver disease was 38%. This prevalence varied according to etiology of liver disease, from 50% in chronic hepatitis C virus (HCV) to less than 10% in alcoholicc cirrhosis and hepatitis B-virus (HBV)-related chronic liver disease. Patients with lymphadenopathy showed significantly higher serum …

Malemedicine.medical_specialtyPathologyCirrhosisAcoustics and UltrasonicsHepatitis C virusBiophysicsAntineoplastic Agentsmedicine.disease_causeChronic liver diseaseGastroenterologyLiver diseaseInternal medicineAbdomenmedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesLymphatic DiseasesUltrasonographyHepatitis B virusHepatitisAnalysis of VarianceRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver DiseasesInterferon-alphaMiddle Agedmedicine.diseasemedicine.anatomical_structureLiverLiver biopsyChronic DiseaseAbdomenFemaleLymph NodesbusinessUltrasound in Medicine & Biology
researchProduct

Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C …

2008

Background and aim We assessed whether the two regimens of pegylated alpha-interferon-2b (PEG-IFN-alpha2b) plus ribavirin and pegylated alpha-interferon-2a (PEG-IFN-alpha2a) plus ribavirin showed differences in terms of sustained virological response, withdrawal due to side-effects and dose adjustment requirements in the treatment of naive chronic hepatitis C virus (HCV) patients. Methods A prospective non-randomized, open-label comparison was made of naive HCV-infected patients undergoing standard 24- or 48-week treatment with two PEG-IFN combined with weight-based dosing regimen of ribavirin (PEG-IFN-alpha2a/ribavirin, n = 91; PEG-IFN-alpha2b/ribavirin, n = 92). Results Sustained virologi…

AdultMalemedicine.medical_specialtyHepacivirusHepatitis C virusHepacivirusInterferon alpha-2medicine.disease_causeGastroenterologyAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundInterferonInternal medicineRibavirinmedicineHumansProspective StudiesProspective cohort studyHepatologymedicine.diagnostic_testbiologybusiness.industryRibavirinGastroenterologyInterferon-alphaHepatitis CHepatitis C ChronicMiddle AgedViral Loadbiology.organism_classificationmedicine.diseaseRecombinant ProteinsTreatment OutcomechemistryLiver biopsyImmunologyDrug Therapy CombinationFemalebusinessViral loadmedicine.drugJournal of gastroenterology and hepatology
researchProduct

Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003)

2006

Background:  Diagnostic and preventive measures have contributed to a change in the epidemiology of acute hepatitis. The purpose of the present paper was to assess the changing prevalence of acute hepatitis from 1982 to 2003. Methods:  Trends in the epidemiology, clinical findings, and outcome of acute viral hepatitis from 1982 to 2003 were examined. A total of 548 episodes of acute hepatitis diagnosed between 1982 and 2003, the clinical course of which was monitored up to the year 2003, were included. Annual changes as well as for the intervals 1982–1992 and 1993–2003 were compared. Results:  Severe infections occurred in 1.3% of cases, with a mortality of 0.6%, with progression into chron…

AdultMalemedicine.medical_specialtyAdolescentVirusHepatitisInternal medicinePharmacovigilanceEpidemiologyPrevalencemedicineHumansHepatitisHepatologybusiness.industryGastroenterologyClinical courseHepatitis AMiddle Agedmedicine.diseaseSurgerySpainAcute DiseaseFemaleViral hepatitisbusinessAcute hepatitisJournal of Gastroenterology and Hepatology
researchProduct

Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis

2004

The purpose of this study was to assess whether serum creatinine concentration alone or associated with other biological parameters was an independent predictor of short-term mortality in patients with decompensated cirrhosis.A total of 212 consecutive episodes of decompensated cirrhosis in patients admitted to the hospital between January 1999 and December 2001 were reviewed retrospectively. Depending on a serum creatinine concentration equal to or greater than 1.5 mg/dL at the time of admission, patients were divided into decompensated cirrhosis with renal failure (101 episodes in 59 patients, aged 69.8 +/- 10 years) and without renal failure (111 episodes in 61 patients, aged 64.5 +/- 13…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisGastroenterologyLiver diseasechemistry.chemical_compoundInternal medicinemedicineHumansDecompensationHospital MortalityRenal InsufficiencySurvival rateSerum AlbuminAgedCreatinineModels Statisticalbusiness.industryGastroenterologyBilirubinMiddle AgedPrognosismedicine.diseaseDecompensated cirrhosisSurgerySurvival RateTreatment OutcomeROC CurveEl NiñochemistryCreatinineFemalebusinessBiomarkersKidney diseaseScandinavian Journal of Gastroenterology
researchProduct

Effect of antioxydants on the flavor characteristics and the gas chromatography/olfactrometry profiles of champagne extracts

1999

International audience

CHAMPAGNE ET VIN MOUSSEUX[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.IDA] Life Sciences [q-bio]/Food engineeringComputingMilieux_MISCELLANEOUS
researchProduct